Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kimberly Goodyear

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
The American Journal of Drug and Alcohol Abuse|September 28, 2021
Alcohol-related changes in behaviors and characteristics from the baseline to the randomization session for treatment and non-treatment seeking participants with alcohol use disorderKimberly Goodyear, Talia R Vasaturo-Kolodner, George A Kenna, et al.
Human Factors|February 2, 2017
A Little Anthropomorphism Goes a Long WayEwart J de Visser, Samuel S Monfort, Kimberly Goodyear, et al.
Addictive Behaviors Reports|September 21, 2023
Access to medication for opioid use disorder supported by telemedicine and healthcare coverage: A web-based survey during the COVID-19 pandemicMollie A Monnig, Samantha E Clark, Hayley Treloar Padovano, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|August 6, 2017
A Phase I randomized clinical trial testing the safety, tolerability and preliminary pharmacokinetics of the mGluR5 negative allosteric modulator GET 73 following single and repeated doses in healthy volunteersCarolina L Haass-Koffler, Kimberly Goodyear, Victoria M Long, et al.
Data in Brief|December 8, 2017
Dataset for Phase I randomized clinical trial for safety and tolerability of GET 73 in single and repeated ascending doses including preliminary pharmacokinetic parametersCarolina L Haass-Koffler, Kimberly Goodyear, Victoria M Long, et al.
Journal of Psychopharmacology (Oxford, England)|January 25, 2018
Administration of the metabotropic glutamate receptor subtype 5 allosteric modulator GET 73 with alcohol: A translational study in rats and humansCarolina L Haass-Koffler, Kimberly Goodyear, Antonella Loche, et al.
Drug and Alcohol Dependence|May 29, 2017
Higher pretreatment blood pressure is associated with greater alcohol drinking reduction in alcohol-dependent individuals treated with doxazosinCarolina L Haass-Koffler, Kimberly Goodyear, William H Zywiak, et al.
International Journal of Environmental Research and Public Health|January 21, 2023
COVID-19-Related Stressors and Clinical Mental Health Symptoms in a Northeast US SampleMollie A Monnig, Samantha E Clark, Jaqueline C Avila, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
The American Journal of Drug and Alcohol Abuse|September 28, 2021
Alcohol-related changes in behaviors and characteristics from the baseline to the randomization session for treatment and non-treatment seeking participants with alcohol use disorderKimberly Goodyear, Talia R Vasaturo-Kolodner, George A Kenna, et al.
Human Factors|February 2, 2017
A Little Anthropomorphism Goes a Long WayEwart J de Visser, Samuel S Monfort, Kimberly Goodyear, et al.
Addictive Behaviors Reports|September 21, 2023
Access to medication for opioid use disorder supported by telemedicine and healthcare coverage: A web-based survey during the COVID-19 pandemicMollie A Monnig, Samantha E Clark, Hayley Treloar Padovano, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|August 6, 2017
A Phase I randomized clinical trial testing the safety, tolerability and preliminary pharmacokinetics of the mGluR5 negative allosteric modulator GET 73 following single and repeated doses in healthy volunteersCarolina L Haass-Koffler, Kimberly Goodyear, Victoria M Long, et al.
Data in Brief|December 8, 2017
Dataset for Phase I randomized clinical trial for safety and tolerability of GET 73 in single and repeated ascending doses including preliminary pharmacokinetic parametersCarolina L Haass-Koffler, Kimberly Goodyear, Victoria M Long, et al.
Journal of Psychopharmacology (Oxford, England)|January 25, 2018
Administration of the metabotropic glutamate receptor subtype 5 allosteric modulator GET 73 with alcohol: A translational study in rats and humansCarolina L Haass-Koffler, Kimberly Goodyear, Antonella Loche, et al.
Drug and Alcohol Dependence|May 29, 2017
Higher pretreatment blood pressure is associated with greater alcohol drinking reduction in alcohol-dependent individuals treated with doxazosinCarolina L Haass-Koffler, Kimberly Goodyear, William H Zywiak, et al.
International Journal of Environmental Research and Public Health|January 21, 2023
COVID-19-Related Stressors and Clinical Mental Health Symptoms in a Northeast US SampleMollie A Monnig, Samantha E Clark, Jaqueline C Avila, et al.
Pageof 3